Mauro David J
SEC CIK 1621172 · EDGAR
BoughtSold
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Mauro David J made no open-market trades at RXRX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | F - Tax | $6.18 | -4,187 | 225.4K | -2% | -$25.9K | |
| 2024-08-19 | 2024-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | F - Tax | $6.69 | -14.1K | 229.6K | -6% | -$94.6K | |
| 2024-05-17 | 2024-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | F - Tax | $10.01 | -867 | 243.8K | -0.4% | -$8,679 | |
| DM | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | A - Grant | $0.00 | +55.8K | 196.8K | +40% | $0 |
| D | 2024-02-13 | 2024-02-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | F - Tax | $10.09 | -1,892 | 244.6K | -0.8% | -$19.1K |
| D | 2023-06-07 | 2023-06-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Mauro David J | Chief Medical Off | A - Grant | $0.00 | +190.7K | 190.7K | New | $0 |
| DM | 2021-10-06 | 2021-10-05 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | S - Sale+OE | $30.96 | -15.0K | 9,092 | -62% | -$464.3K |
| D | 2021-10-06 | 2021-10-05 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | M - OptEx | $1.89 | +15.0K | 15.0K | New | +$28.4K |
| DM | 2021-09-09 | 2021-09-07 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | S - Sale+OE | $36.68 | -15.0K | 0 | -100% | -$550.3K |
| D | 2021-09-09 | 2021-09-07 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | M - OptEx | $1.89 | +15.0K | 15.0K | New | +$28.4K |
| D | 2021-08-09 | 2021-08-05 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | M - OptEx | $1.89 | +15.0K | 15.0K | New | +$28.4K |
| DM | 2021-08-09 | 2021-08-05 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | S - Sale+OE | $31.09 | -15.0K | 6,821 | -69% | -$466.4K |
| DM | 2021-07-08 | 2021-07-06 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | S - Sale+OE | $27.48 | -15.0K | 4,555 | -77% | -$412.1K |
| D | 2021-07-08 | 2021-07-06 | PRLD | Prelude Therapeutics Inc | Mauro David J | Chief Medical Off | M - OptEx | $1.89 | +15.0K | 15.0K | New | +$28.4K |
Purchase Sale Sale after option exercise All abbreviations